Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.8 USD | +1.87% | -.--% | -22.14% |
05-16 | Transcript : EL.En. S.p.A., Q1 2024 Earnings Call, May 16, 2024 | |
05-15 | EL.En. S.p.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- The company is in a robust financial situation considering its net cash and margin position.
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The opinion of analysts covering the stock has improved over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- Revenue estimates are regularly revised downwards for the current and coming years.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-22.14% | 810M | - | ||
-31.56% | 216M | - | ||
0.00% | 121M | - | - | |
-26.78% | 84.74M | - | - | |
+3.92% | 55.64M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- ELN Stock
- ELEAF Stock
- Ratings EL.En. S.p.A.